Mental health in heart failure put under the spotlight in new call to action
20 July 2023
The HFPN published a new call to action to raise awareness of the relationship between heart failure and mental health, and drive change for this issue at EU level.
New briefing provides heart failure advocates with actionable ways to improve access to best-practice care in Germany
15 May 2023
The final advocacy briefing in our From guidelines to action series highlights the opportunities for heart failure advocates to improve care in Germany.
Innovation in heart failure: how can we ensure early diagnosis?
08 December 2022
Our ‘Innovation in heart failure: early diagnosis in community settings’ report outlines the urgent need to boost timely diagnosis and presents a variety of promising initiatives.
How can heart failure advocates in Spain seize current opportunities to improve care?
22 September 2022
Our latest policy brief attempts to answer this question, examining existing opportunities and mechanisms to advocate for guideline-recommended care in Spain.
People receiving cancer treatment need integrated care to manage heart failure risk
06 July 2022
The Heart Failure Policy Network (HFPN) has launched Spotlight on cancer treatment and heart failure, which highlights the need for integrated care and collaboration between oncology and cardiology services.
The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from AstraZeneca, Roche Diagnostics, Bayer and Netherlands Heart Institute. The content produced by the Network is not biased toward any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members. All members provide their time for free. The Network is hosted by The Health Policy Partnership.
